Right Patient. Right Time. Right Line.

Vascular Access requires timely assessment, planning, insertion and follow-up. Appropriate device selection can impact the length of stay and complications, therefore, early assessment of a patient who requires a vascular access device should be considered upon admission.

The BioFlo Midline Catheter is an effective solution to preserving a patient’s peripheral access. It provides a cost-effective alternative to multiple IV site rotations for patients who need short-term venous access. This improves the likelihood that the patient will receive his or her ordered therapy, which may lead to a shorter hospital stay, and improved patient satisfaction.

Proven to Reduce Thrombus Accumulation, In Vitro

The BioFlo Midline Catheter is the only midline catheter with Endexo Technology, providing a catheter material more resistant to platelet aggregation1. This novel, disruptive technology is present throughout the catheter shaft including the intraluminal, extraluminal and cut surface of the catheter, and is present for the life of the catheter.

BioFlo Midline Catheter

  • X-ray confirmation is not required after placement
  • Visibly marked as a midline catheter to aid in identification
  • Multiple kit configurations to meet clinician needs:
    • Maximal Barrier Nursing Kit
    • MST KitCatheter Only Kit
    • Available with standard stylet or nitinol guidewires only
  • Power Injectable
BioFlo Midline Catheter

Find a Sales Rep

Click “Find a Sales Rep” and fill out your information along with your product interest(s) and a member of our team will contact you.

  • Preferred Method of Contact
  • Please select the products you are interested in below.

  • Venous Disease
  • Vascular Interventions
  • Thrombus Management
  • Vascular Access
  • Oncology
  • By clicking "Contact Me" I am agreeing that I have read and accept the Privacy Policy and Terms of Use. You may also contact our team directly at: 1-800-772-6446 Or, by email at: customerservice@angiodynamics.com
  • This field is for validation purposes and should be left unchanged.

Patients Are The Focus

John’s Story

I had my career, my family, my wife, and my daughter…

John Neet, a Stage III pancreatic cancer patient, shares the story about his fight.